Metabolomics Creative Proteomics
Metabolomics Sample Submission Guidelines Inquiry

Cyclic Nucleotide and Second Messenger Analysis: cAMP, cGMP, and cGAMP Quantification

Cyclic nucleotides (cAMP, cGMP, and 2'3'-cGAMP) are high-turnover second messengers that regulate critical signaling pathways, yet their measurement is often hindered by rapid enzymatic degradation and matrix-driven ion suppression. Creative Proteomics provides Targeted LC-MS/MS Analysis—combining immediate quenching with femtomole-level sensitivity—to deliver definitive, absolute quantification for STING signaling, GPCR research, and drug discovery.

  • Absolute Specificity: Targeted MRM detection distinguishes mammalian 2'3'-cGAMP from bacterial isomers, eliminating the cross-reactivity risks of conventional ELISA.
  • Stability-Locked Protocols: Immediate enzymatic quenching (HCl/HClO₄) prevents PDE-driven turnover, preserving the true signaling state at the point of collection.
  • Trace-Level Sensitivity: Achieves fmol/picogram-level detection limits, essential for capturing low-abundance endogenous signals in primary cells and biopsies.
  • Matrix-Validated Accuracy: Isotope-dilution (IDMS) and rigorous QC packages (R² ≥ 0.995) ensure high-integrity, publication-ready data across diverse sample types.
CONTACT EXPERT
  • Service Details
  • FAQ
  • Publications
  • Submit Your Inquiry

Cyclic nucleotides—cAMP, cGMP, and cGAMP—are essential second messengers that convert extracellular cues into precise intracellular responses. However, due to their extremely low endogenous levels and rapid enzymatic turnover, they remain difficult to quantify with conventional metabolomics methods.

Creative Proteomics offers a specialized LC-MS/MS platform optimized for the absolute quantification of these labile molecules, delivering the sensitivity, specificity, and reproducibility required for drug development, signaling studies, and mechanism-of-action research.

What Problems This Service Helps You Solve

Measuring cyclic nucleotides requires more than just high-end hardware; it requires a specialized approach to biology and chemistry. Our service helps you solve:

  • The Sensitivity Gap: Detecting femtomole-level concentrations in limited samples like primary cells or tumor biopsies.
  • Rapid Enzymatic Turnover: Preventing the immediate degradation of cAMP/cGMP by phosphodiesterases (PDEs) during sample collection.
  • Isomer Ambiguity: Specifically distinguishing between signaling isomers like 2'3'-cGAMP (mammalian) and 3'3'-cGAMP (bacterial) that ELISA cannot resolve.
  • Matrix Suppression: Eliminating interference from high-salt or complex biological backgrounds using optimized HILIC separation.

Service Options And Analyte Coverage For cAMP, cGMP, And cGAMP

Choose a focused single-analyte readout, or add pathway context with a panel. Optional variants and add-ons are available when they improve interpretation.

What We Can Quantify

Scope Included Analytes When To Choose
Single Analyte cAMP or cGMP or cGAMP One messenger is your primary decision metric
Core Panel cAMP + cGMP + cGAMP You want signaling context under one QC plan
Optional Variants (Project-Dependent) 2'3'-cGAMP, 3'3'-cGAMP When isomer specificity matters (standards/matrix dependent)
Related Nucleotides (Add-On) AMP, GMP, ATP, GTP (and others as needed) Upstream/downstream interpretation (project-defined)

Built-In Quality Options

  • Standard QC: calibration + QC samples + blanks/carryover checks (fit-for-purpose)
  • Enhanced QC for challenging matrices: spike/recovery and matrix-effect checks when backgrounds vary widely

Quick Decision Guide: Single-Analyte Vs. Panel

Your Research Goal Recommended Scope Why This Works Common Enhancements
Verify whether one messenger changes Single analyte Fastest, most focused interpretation Absolute quantification + Standard QC
Interpret signaling direction or balance Panel Context reduces misinterpretation Project-defined ratio-style summaries
STING pathway engagement cGAMP ± Panel Targets pathway messenger directly Isomer-aware support; Enhanced QC
Multiple matrices / variable backgrounds Panel + Enhanced QC Improves comparability across sample types Spike/recovery; matrix-effect checks

Advantages Of Targeted LC-MS/MS For Second Messengers

  • Sensitivity (Project-Dependent): LLOQ can be method-optimized for low-abundance cyclic nucleotides (matrix-dependent).
  • Isomer Specificity: MRM workflows may distinguish 2'3' vs 3'3-cGAMP when standards and chromatography feasibility support it.
  • QC Targets (Fit-For-Purpose): QC precision targets such as CV ≤10% and strong calibration linearity can be set based on matrix and study needs (IDMS optional).
  • Stability Control: Immediate quenching with cold acidic extraction helps preserve labile cyclic nucleotides by minimizing PDE activity.

Our LC-MS/MS Workflow for Cyclic Nucleotide Analysis

Targeted LC-MS/MS workflow for cAMP, cGMP, and cGAMP quantification with rapid quenching, UHPLC separation, MRM detection, and QC-backed reporting.

Analytical Platform and Key Parameters

We quantify cyclic nucleotides using a targeted UHPLC–triple quadrupole LC-MS/MS platform configured for MRM, designed for low-abundance second messengers in complex research matrices.

Core instruments

  • Agilent 1290 UHPLC System
  • Agilent 6495C Triple Quadrupole LC/MS (MRM)

Key parameters (typical approach)

Parameter Typical Setting / Approach Why It Matters
Acquisition MRM High specificity in complex matrices
Ionization ESI (polarity optimized per analyte/matrix) Supports sensitivity and comparability
LC Strategy Polar-friendly UHPLC (e.g., HILIC or equivalent) Improves retention, reduces interferences
Quantification Calibration + QC; IDMS optional Stronger accuracy/precision
Matrix Controls Optional matrix-effect & spike/recovery checks Better cross-matrix confidence
cGAMP Specificity Optional isomer-aware support (feasibility-dependent) Distinguishes 2'3' vs 3'3 when needed
Agilent 6495C Triple Quadrupole

Agilent 6495C Triple Quadrupole (Figure from Agilent)

Agilent 1290 UHPLC System

Agilent 1290 UHPLC System (Figure from Agilent)

Sample Submission and Preparation Guidelines

Use the table below as a practical starting point. If you have limited material, mixed matrices, or proprietary buffers, we can scope a matrix-fit plan.

Sample Type Typical Suggested Amount (Starting Point) Container Storage & Shipping (General) Notes
Cell pellet 1–5 million cells (quench immediately) Screw-cap tube Freeze; ship cold/frozen Minimize freeze–thaw
Cell lysate 100–200 μL Low-bind tube Freeze; ship cold/frozen Provide buffer composition if possible
Tissue 20–50 mg (flash-frozen) Cryovial Freeze; ship cold/frozen Record wet weight
Plasma / serum 100–200 μL Screw-cap tube Freeze preferred Note anticoagulant (if applicable)
CSF 50–100 μL Low-bind tube Freeze; ship cold/frozen Low abundance—enhanced QC recommended
Culture media / supernatant 200–500 μL Screw-cap tube Freeze preferred Note medium/serum type

Technical Pro-tip (Handling & Quenching): Cyclic nucleotides are sensitive to endogenous phosphodiesterases (PDEs). To preserve the true signaling state, quench immediately using cold acidic extraction (e.g., ~0.1 M HCl or HClO₄) and keep samples cold/frozen before shipping.

What You Receive

  • Quantitative results tables (CSV/Excel): concentrations or response ratios, sample IDs, and normalization fields (as defined during scoping)
  • Calibration summary: curve fit details and quant range notes (project-defined)
  • QC documentation: QC performance, blanks/carryover checks, and matrix-control results when included
  • Method snapshot: platform + workflow description suitable for internal documentation
  • Optional raw outputs: chromatograms/integration exports (as requested)
Overlaid MRM chromatograms for blank, spike, and sample highlighting specific cGAMP peak with no false positives.

MRM chromatogram overlay showing cGAMP peak in sample and spike, absent in blank, confirming assay specificity.

Calibration and residual plots demonstrating accurate, reproducible cGAMP quantification with excellent linearity.

Standard curve with residuals showing high linearity and minimal deviation across cGAMP quantification range.

Color-coded heatmap showing matrix effect and recovery rates across sample types in cyclic nucleotide analysis.

Matrix recovery and process efficiency heatmap across sample types confirms method robustness and QC consistency.

Scatter plot showing reproducible quantification of cyclic nucleotides across QC levels and analytical runs.

QC replicate data for low/mid/high levels showing consistent measurement within acceptance thresholds.

Applications of cAMP, cGMP, and cGAMP Quantification

STING Pathway Activation Studies

Detect and quantify cGAMP to confirm innate immune signaling in cellular or engineered systems.

Phosphodiesterase Inhibitor Evaluation

Measure intracellular cAMP/cGMP accumulation to assess compound efficacy and dose–response.

GPCR-Linked Drug Screening

Use second messenger quantification as pharmacodynamic readouts for agonist/antagonist testing.

Mechanistic Toxicology

Monitor second messenger shifts under toxicant or stress exposure to identify pathway perturbations.

Reporter Assay Validation

Cross-validate indirect readouts (e.g., luciferase, ELISA) with direct LC-MS/MS quantification.

Biomarker Exploration in Complex Matrices

Profile cAMP, cGMP, and cGAMP in tissues, CSF, or plasma to support early-stage translational research.

Q: Why choose LC-MS/MS over ELISA for cGAMP analysis?

LC-MS/MS ensures absolute specificity, distinguishing 2'3'-cGAMP from 3'3'-isomers. It eliminates ELISA cross-reactivity and enables multiplexing.

Q: How is sample stability maintained for cyclic nucleotides?

Cold acid quenching (HCl/HClO4) instantly inactivates PDEs. This "locks" the metabolic state, preventing rapid degradation of labile nucleotides.

Q: What is the typical sensitivity (LLOQ) for cGAMP?

Our Agilent 6495C platform reaches low pg/mL (fmol) limits. This is critical for trace endogenous cGAMP in primary immune cells or biopsies.

Q: How is quantification data normalized for research?

Results are normalized by protein, cell count, or tissue weight. cAMP/cGMP ratios help interpret GPCR and NO-signaling homeostasis shifts.

Q: Does the platform support bacterial messengers like c-di-GMP?

We use HILIC-MS/MS to quantify c-di-GMP and c-di-AMP, providing high-resolution data for bacterial biofilm and virulence research.

Q: What is the benefit of Isotope-Dilution (IDMS)?

IDMS uses stable isotope standards to correct for matrix effects and recovery loss, ensuring the absolute accuracy required for IND filings.

MS CETSA functional proteomics uncovers DNA repair programs leading to gemcitabine resistance

Liang, Y. Y., et al.

Journal: Nature Communications

Year: 2025

DOI: https://doi.org/10.1038/s41467-025-59505-8

MS-CETSA functional proteomics uncovers new DNA-repair programs leading to Gemcitabine resistance

Nordlund, P., Liang, Y. Y., et al.

Journal: Research Square

Year: 2024

DOI: https://doi.org/10.21203/rs.3.rs-4820265/v1

Teriflunomide/leflunomide synergize with chemotherapeutics by decreasing mitochondrial fragmentation via DRP1 in SCLC

Mirzapoiazova, T., et al.

Journal: iScience

Year: 2024

DOI: https://doi.org/10.1016/j.isci.2024.110132

NUDT22 promotes cancer growth through pyrimidine salvage and the TCA cycle

Walter, M., et al.

Journal: Oncogene

Year: 2022

DOI: https://doi.org/10.21203/rs.3.rs-1491465/v1

Unscheduled m6A Deposition in RNA via m6ATP Incorporation by DNA Polymerases

Qu, F., et al.

Journal: International Journal of Molecular Sciences

Year: 2025

DOI: https://doi.org/10.3390/ijms26199263

Hierarchical glycolytic pathways control the carbohydrate utilization regulator in human gut Bacteroides

Kabonick, S. G., et al.

Journal: Nature Communications

Year: 2025

DOI: https://doi.org/10.1038/s41467-025-59704-3

For Research Use Only. Not for use in diagnostic procedures.
inquiry

Get Your Custom Quote

Connect with Creative Proteomics Contact UsContact Us
return-top